The management of treatment-resistant schizophrenia

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Several important developments in the pharmacotherapy of treatment-resistant schizophrenia have occurred over the past year. These developments include the resolution of questions related to the clinical application and safety of clozapine, the widespread introduction of risperidone, and new approaches to the treatment of negative symptoms and cognitive impairment. These developments will be critically examined and future challenges for the management of treatment-resistant schizophrenia will be discussed.

Original languageEnglish (US)
Pages (from-to)41-44
Number of pages4
JournalCurrent Opinion in Psychiatry
Volume8
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Schizophrenia
Risperidone
Clozapine
Therapeutics
Safety
Drug Therapy
Cognitive Dysfunction

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The management of treatment-resistant schizophrenia. / Breier, Alan.

In: Current Opinion in Psychiatry, Vol. 8, No. 1, 1995, p. 41-44.

Research output: Contribution to journalArticle

@article{3c61a51cc96d47809d593c8c9e1ac1d2,
title = "The management of treatment-resistant schizophrenia",
abstract = "Several important developments in the pharmacotherapy of treatment-resistant schizophrenia have occurred over the past year. These developments include the resolution of questions related to the clinical application and safety of clozapine, the widespread introduction of risperidone, and new approaches to the treatment of negative symptoms and cognitive impairment. These developments will be critically examined and future challenges for the management of treatment-resistant schizophrenia will be discussed.",
author = "Alan Breier",
year = "1995",
doi = "10.1097/00001504-199501000-00010",
language = "English (US)",
volume = "8",
pages = "41--44",
journal = "Current Opinion in Psychiatry",
issn = "0951-7367",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The management of treatment-resistant schizophrenia

AU - Breier, Alan

PY - 1995

Y1 - 1995

N2 - Several important developments in the pharmacotherapy of treatment-resistant schizophrenia have occurred over the past year. These developments include the resolution of questions related to the clinical application and safety of clozapine, the widespread introduction of risperidone, and new approaches to the treatment of negative symptoms and cognitive impairment. These developments will be critically examined and future challenges for the management of treatment-resistant schizophrenia will be discussed.

AB - Several important developments in the pharmacotherapy of treatment-resistant schizophrenia have occurred over the past year. These developments include the resolution of questions related to the clinical application and safety of clozapine, the widespread introduction of risperidone, and new approaches to the treatment of negative symptoms and cognitive impairment. These developments will be critically examined and future challenges for the management of treatment-resistant schizophrenia will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=0028836739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028836739&partnerID=8YFLogxK

U2 - 10.1097/00001504-199501000-00010

DO - 10.1097/00001504-199501000-00010

M3 - Article

VL - 8

SP - 41

EP - 44

JO - Current Opinion in Psychiatry

JF - Current Opinion in Psychiatry

SN - 0951-7367

IS - 1

ER -